ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT / FBLN2 axis
Journal of Cellular and Molecular Medicine · 2024-02 · 28 (4)
DOI: 10.1111/jcmm.18113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 08.02.2024. Verfasst von Kanger Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Anoikis, Stomach Neoplasms, Calcium-Binding Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of Medical Research of Jiangsu Commission of Health, Suzhou Special Project on Clinical Key Diseases Treatment Technology of Suzhou Commission of Health, iangsu Provincial Medical Key Discipline (No. ZDXK202246); the Natural Science Foundation of the Jiangsu Higher Education Institutions of China iangsu Provinci….
Abstract (Originalsprache)
The resistance to anoikis plays a critical role in the metastatic progression of various types of malignancies, including gastric cancer (GC). Nevertheless, the precise mechanism behind anoikis resistance is not fully understood. Here, our primary focus was to examine the function and underlying molecular mechanism of Integrin beta‐like 1 (ITGBL1) in the modulation of anoikis resistance and metastasis in GC. The findings of our investigation have demonstrated that the overexpression of ITGBL1 significantly augmented the resistance of GC cells to anoikis and promoted their metastatic potential, while knockdown of ITGBL1 had a suppressive effect on both cellular processes in vitro and in vivo. Mechanistically, we proved that ITGBL1 has a role in enhancing the resistance of GC cells to anoikis and promoting metastasis through the AKT/Fibulin‐2 (FBLN2) axis. The inhibition of AKT/FBLN2 signalling was able to reverse the impact of ITGBL1 on the resistance of GC cells to anoikis and their metastatic capability. Moreover, the expression levels of ITGBL1 were found to be significantly elevated in the cancerous tissues of patients diagnosed with GC, and there was a strong correlation observed between high expression levels of ITGBL1 and worse prognosis among individuals diagnosed with GC. Significantly, it was revealed that within our cohort of GC patients, individuals exhibiting elevated ITGBL1 expression and diminished FBLN2 expression experienced the worst prognosis. In conclusion, the findings of our study indicate that ITGBL1 may serve as a possible modulator of resistance to anoikis and the metastatic process in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Suzhou, China.
- Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Tongguo Shi
Förderung
- Key Project of Medical Research of Jiangsu Commission of Health
- Suzhou Special Project on Clinical Key Diseases Treatment Technology of Suzhou Commission of Health
- iangsu Provincial Medical Key Discipline (No. ZDXK202246); the Natural Science Foundation of the Jiangsu Higher Education Institutions of China iangsu Provinci…
- People's Livelihood and Science and Technology project of Department of Science and Technology of Suzhou
- Suzhou "Science and Education Revitalize Health" Youth Science and Technology Project
Zitieren
APA
Shen, K., Xia, W., Wang, K., Li, J., Xu, W., Liu, H., Yang, K., Zhu, J., Wang, J., Xi, Q., Shi, T., & Li, R. (2024). ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT / FBLN2 axis. Journal of Cellular and Molecular Medicine, 28(4). https://doi.org/10.1111/jcmm.18113
Vancouver
Shen K, Xia W, Wang K, Li J, Xu W, Liu H, et al. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT / FBLN2 axis. Journal of Cellular and Molecular Medicine. 2024;28(4). doi:10.1111/jcmm.18113
BibTeX
@article{Shen2024,
author = {Shen, Kanger and Xia, Wei and Wang, Kun and Li, Juntao and Xu, Wei and Liu, Haoran and Yang, Kexi and Zhu, Jinghan and Wang, Jiayu and Xi, Qinhua and Shi, Tongguo and Li, Rui},
title = {ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT / FBLN2 axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {4},
doi = {10.1111/jcmm.18113}
}
EUVIMED